Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors.
Ghosh, A.K., Xi, K., Grum-Tokars, V., Xu, X., Ratia, K., Fu, W., Houser, K.V., Baker, S.C., Johnson, M.E., Mesecar, A.D.(2007) Bioorg Med Chem Lett 17: 5876-5880
- PubMed: 17855091 
- DOI: https://doi.org/10.1016/j.bmcl.2007.08.031
- Primary Citation of Related Structures:  
2QIQ - PubMed Abstract: 
Structure-based design, synthesis, and biological evaluation of a series of peptidomimetic severe acute respiratory syndrome-coronavirus chymotrypsin-like protease inhibitors are described. These inhibitors were designed and synthesized based upon our X-ray crystal structure of inhibitor 1 bound to SARS-CoV 3CLpro. Incorporation of Boc-Ser as the P(4)-ligand resulted in enhanced SARS-CoV 3CLpro inhibitory activity. Structural analysis of the inhibitor-bound X-ray structure revealed high binding affinity toward the enzyme.
Organizational Affiliation: 
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA. akghosh@purdue.edu